Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test



Status:Completed
Conditions:Colorectal Cancer, Cancer, Cancer, Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases, Oncology
Healthy:No
Age Range:18 - 90
Updated:10/14/2017
Start Date:March 2010
End Date:March 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Collection of Anal Specimens for Assessment of Anal Cancer Using the HC2 High-Risk DNA Test (QIAGEN)

This is a study to determine if HC2 HPV testing in the anal canal can detect high-risk HPV
and whether this aids in identifying individuals are risk for anal cancer or precancerous
lesions.


Inclusion Criteria:

1. male or female 18 years of age or older

2. screened for anal dysplasia, including MSM and women -

Exclusion Criteria:

1. subject has had a previous treatment for anal cancer.

2. subjects that have used enemas or other foreign substances, in the anal canal or anal
sex within 24 hours of collection.

3. subjects that have bleeding disorders or use anticoagulation treatments. -
We found this trial at
1
site
Laser Surgery Care
New York, New York 10011
?
mi
from
New York, NY
Click here to add this to my saved trials